Form 4 for CTKB Cytek Biosciences, Inc.
Accepted 2023-10-05 00:00:00 ET · period of report 2023-09-14 · accession 0001209191-23-052263 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2023-10-05 | 2023-09-14 | CTKB | Jiang Wenbin | Pres, CEO, Dir | G - Gift | $0.00 | -2.29M | 5.32M | -30% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2023-09-14 | G | D | 2,290,000 | $0.00 | 5,315,796 | D | — | — |